Eledon Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities researchers at Leerink Partnrs issued their Q1 2024 earnings estimates for shares of Eledon Pharmaceuticals in a research report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will earn ($0.33) per share for the quarter. The consensus estimate for Eledon […]

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Eledon Pharmaceuticals (NASDAQ:ELDN – Free Report) had its target price cut by HC Wainwright from $25.00 to $13.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Eledon Pharmaceuticals’ FY2023 earnings at ($1.31) EPS. A number of other research firms […]

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) – HC Wainwright issued their Q2 2023 EPS estimates for Eledon Pharmaceuticals in a research report issued to clients and investors on Friday, May 26th. HC Wainwright analyst V. Bernardino anticipates that the company will earn ($0.47) per share for the quarter. The consensus estimate for Eledon Pharmaceuticals’ […]